Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-09-2022 | Itraconazole | Case report

Omalizumab

Allergic bronchopulmonary Aspergillosis flare: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Jaroenpuntaruk V, et al. ALLERGIC ASTHMA ON CHRONIC OMALIZUMAB THERAPY: HOW IT INTERFERES WITH THE MANAGEMENT OF RECURRENT ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS. Journal of General Internal Medicine 37 (Suppl. 2): S352, Jun 2022. Available from: URL: http://doi.org/10.1007/s11606-022-07653-8 [abstract] Jaroenpuntaruk V, et al. ALLERGIC ASTHMA ON CHRONIC OMALIZUMAB THERAPY: HOW IT INTERFERES WITH THE MANAGEMENT OF RECURRENT ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS. Journal of General Internal Medicine 37 (Suppl. 2): S352, Jun 2022. Available from: URL: http://​doi.​org/​10.​1007/​s11606-022-07653-8 [abstract]
Metadata
Title
Omalizumab
Allergic bronchopulmonary Aspergillosis flare: case report
Publication date
01-09-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-22754-x

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

BBIBP-CorV

Case report

Ibuprofen

Case report

Aspirin/warfarin